메뉴 건너뛰기




Volumn 81, Issue 5, 2008, Pages 405-408

Clindamycin phosphate 1.2%-tretinoin 0.025% gel: Vehicle characteristics, stability, and tolerability

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; CLINDAMYCIN-2-PHOSPHATE; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; DRUG VEHICLE; RETINOIC ACID;

EID: 44649122032     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (11)

References (9)
  • 1
    • 34548436461 scopus 로고    scopus 로고
    • Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris
    • Schlessinger J, Menter A, Gold M, et al. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:607-615.
    • (2007) J Drugs Dermatol , vol.6 , pp. 607-615
    • Schlessinger, J.1    Menter, A.2    Gold, M.3
  • 2
    • 37049033269 scopus 로고    scopus 로고
    • Safety of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: Results from a 52-week open-label study
    • Poster presented at: March 3-9, Maui, HI
    • Leyden JJ, Wortzman M, Plott T. Safety of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: results from a 52-week open-label study. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
    • (2007) 31st Hawaii Dermatology Seminar
    • Leyden, J.J.1    Wortzman, M.2    Plott, T.3
  • 3
    • 37049032120 scopus 로고    scopus 로고
    • A novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: Efficacy in patients with mild, moderate, and severe baseline acne
    • Poster presented at: March 3-9, Maui, HI
    • Leyden JJ, Plott T, Wortzman M. A novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: efficacy in patients with mild, moderate, and severe baseline acne. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
    • (2007) 31st Hawaii Dermatology Seminar
    • Leyden, J.J.1    Plott, T.2    Wortzman, M.3
  • 4
    • 44649108644 scopus 로고    scopus 로고
    • Unique aqueous formulation results in reduced risk of tretinoin-induced irritation bioassay
    • Poster presented at: March 3-9, Maui, HI
    • Plott RT. Unique aqueous formulation results in reduced risk of tretinoin-induced irritation bioassay. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
    • (2007) 31st Hawaii Dermatology Seminar
    • Plott, R.T.1
  • 5
    • 33646741602 scopus 로고    scopus 로고
    • Evaluation of a patented pad formulation of benzoyl peroxide in combination with a topical retinoid: Chemical stability, efficacy, and tolerability
    • Del Rosso JQ. Evaluation of a patented pad formulation of benzoyl peroxide in combination with a topical retinoid: chemical stability, efficacy, and tolerability. Cosmet Dermatol. 2006;19:93-97.
    • (2006) Cosmet Dermatol , vol.19 , pp. 93-97
    • Del Rosso, J.Q.1
  • 6
    • 44649104827 scopus 로고    scopus 로고
    • Clindamycin phosphate 1.2%/tretinoin 0.025% gel: Vehicle characteristics, stability and tolerability
    • Poster presented at: October 18-21, Las Vegas, NV
    • Del Rosso JQ, Bhambri S, Momin S. Clindamycin phosphate 1.2%/tretinoin 0.025% gel: vehicle characteristics, stability and tolerability. Poster presented at: Fall Clinical Dermatology Conference; October 18-21, 2007; Las Vegas, NV.
    • (2007) Fall Clinical Dermatology Conference
    • Del Rosso, J.Q.1    Bhambri, S.2    Momin, S.3
  • 7
    • 44649115517 scopus 로고    scopus 로고
    • Data on file. Scottsdale, AZ: Medicis Pharmaceutical Corporation; 2007.
    • Data on file. Scottsdale, AZ: Medicis Pharmaceutical Corporation; 2007.
  • 8
    • 37049032120 scopus 로고    scopus 로고
    • A novel gel formulation of tretinoin and clindamycin is not associated with retinoid induced flaring of inflammatory acne
    • Poster presented at: March 3-9, Maui, HI
    • Leyden JJ, Plott T, Wortzman M. A novel gel formulation of tretinoin and clindamycin is not associated with retinoid induced flaring of inflammatory acne. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
    • (2007) 31st Hawaii Dermatology Seminar
    • Leyden, J.J.1    Plott, T.2    Wortzman, M.3
  • 9
    • 44649138299 scopus 로고    scopus 로고
    • Comparison of facial tolerance of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate, 0.1% adapalene gel, and 0.1% tretinoin microsphere gel
    • Poster presented at: March 3-9, Maui, HI
    • Leyden JJ, Plott T, Wortzman M. Comparison of facial tolerance of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate, 0.1% adapalene gel, and 0.1% tretinoin microsphere gel. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
    • (2007) 31st Hawaii Dermatology Seminar
    • Leyden, J.J.1    Plott, T.2    Wortzman, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.